Pharmaceutical major Cipla on Tuesday reported a 49 per cent year-on-year (YoY) increase in its consolidated net profit for the December quarter (Q3 FY25) at Rs 1,574.6 crore, from Rs 1,068.5 crore in the same quarter last year (Q2 FY25).
The company’s revenue from operations grew by 7 per cent YoY to Rs 7,073 crore, compared to Rs 6,604 crore in Q3 FY24, according to its exchange filing.
However, it remained nearly flat on a quarter-on-quarter (QoQ) basis, with revenue standing at Rs 7,051 crore in Q2 FY25.
Revenue from its India business grew by 10 per cent YoY to Rs 3,146 crore, with its branded prescription business outperforming market growth in key therapies.